Issues impacting lab regulations and reimbursement
S. 610 - the Protecting Medicare & American Farmers from Sequester Cuts Act
Regulation of laboratory developed tests
H.R. 4128/S.2209 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act
Duration: October 1, 2018
to
November 19, 2021
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations
Spending: about $240,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Labor - Dept of (DOL)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2021
Polsinelli PC terminated an engagement in which they represented American Society for Histocompatibility & Immunogenetics on Jan. 18, 2022.
Original Filing: 301325214.xml
Lobbying Issues
Issues impacting lab regulations and reimbursement
S. 610 - the Protecting Medicare & American Farmers from Sequester Cuts Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of laboratory developed tests
H.R. 4128/S.2209 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301364.xml
Lobbying Issues
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of laboratory developed tests
H.R. 4128/S.2209 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
2nd Quarter, 2021
In Q2, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on July 14, 2021.
Original Filing: 301275902.xml
Lobbying Issues
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of laboratory developed tests
H.R. 4128/S.2209 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
1st Quarter, 2021
In Q1, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on April 13, 2021.
Original Filing: 301252347.xml
Lobbying Issues
Issues related to kidney health and kidney transplant access
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of laboratory developed tests
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on Jan. 18, 2021.
Original Filing: 301232982.xml
Lobbying Issues
H.R. 5534, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
Issues impacting lab regulations and reimbursement
H.R. 2477 - Beneficiary Enrollment Notification and Eligibility Simplification Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 6102/ S. 3404, VALID Act of 2020
S.3317 - LOST Organs Act of 2020
H.R.6800 - The Heroes Act
H.R. 7017/ S.3769 - Right to Test Act
Regulation of laboratory developed tests
H.R. 4764 - Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies (TRANSPLANT) ActAgencies lobbied: House, Senate
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, FY2021
H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
H.R. 7617 - Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
H.R. 133 - Consolidated Appropriations Act, 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210678.xml
Lobbying Issues
H.R. 5534, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 6102/ S. 3404, VALID Act of 2020
S.3317 - LOST Organs Act of 2020
H.R.6800 - The Heroes Act
H.R. 7017/ S.3769 - Right to Test Act
Regulation of laboratory developed tests
H.R. 4764 - Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies (TRANSPLANT) ActAgencies lobbied: House, Senate
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, FY2021
H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
H.R. 7617 - Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on July 14, 2020.
Original Filing: 301187899.xml
Lobbying Issues
H.R. 5534, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
H.R. 6102/ S. 3404, VALID Act of 2020
S.3317 - LOST Organs Act of 2020
H.R.6800 - The HEROES Act H.R. 7017/ S.3769 - Right to Test Act
Regulation of laboratory developed tests
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, FY2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on April 15, 2020.
Original Filing: 301167303.xml
Lobbying Issues
- H.R. 5534, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
- Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
- Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136)
H.R. 6201, the Families First Coronavirus Response Act
H.R. 6047, the Coronavirus Preparedness and Response Supplemental Appropriations Act
S. 2063, Organ Procurement Optimization Act
H.R. 6102/ S. 3404, VALID Act of 2020
S.3317 - LOST Organs Act of 2020
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
Budget for Americas Future - Presidents Budget FY 2021
Related Agencies Appropriations Act, FY2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Labor - Dept of (DOL)
4th Quarter, 2019
In Q4, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107855.xml
Lobbying Issues
- The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534)
- Issues impacting lab regulations and reimbursement
- The Laboratory Access for Beneficiaries (LAB) Act (H.R. 3584)
- Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
S. 2063, Organ Procurement Optimization Act
VALID Act, Verifying Accurate, Leading-edge IVCT Development Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2740 - Departments of Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
H.R. 1865, Further Consolidated Appropriations Act, 2020 [P.L. 116-94]
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on Oct. 14, 2019.
Original Filing: 301065123.xml
Lobbying Issues
Issues related to transplant Patients and Anti-Rejection Drugs
Issues impacting lab regulations and reimbursement
The Laboratory Access for Beneficiaries (LAB) Act (H.R. 3584),
Issues related to kidney health and kidney transplant access - Executive Order 13879 - Advancing American Kidney Health
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
S. 2063, Organ Procurement Optimization Act
VALID Act, Verifying Accurate, Leading-edge IVCT Development Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on July 12, 2019.
Original Filing: 301045086.xml
Lobbying Issues
Issues related to transplant Patients and Anti-Rejection Drugs
Issues impacting lab regulations and reimbursement
Agencies lobbied: House, Senate
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 2063, Organ Procurement Optimization Act
VALID Act, Verifying Accurate, Leading-edge IVCT Development Act
Agencies lobbied: House, Senate
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $20,000. The report was filed on April 15, 2019.
Original Filing: 301025588.xml
Lobbying Issues
CMS and FDA jurisdiction for the following:
Organ Procurement Optimization Act
VALID Act, Verifying Accurate, Leading-edge IVCT Development Act
Issues impacting lab regulations and reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, Polsinelli PC lobbied for American Society for Histocompatibility & Immunogenetics , earning $10,000. The report was filed on Jan. 16, 2019.
Original Filing: 301005826.xml
Lobbying Issues
Issues relating to Medicare reimbursement for clinical laboratory services; Appropriate regulatory and oversight framework
Legislation relating to regulation of in vitro clinical tests and laboratory developed tests
Verifying Accurate, Leading-edge IVCT Development (VALID) Act
Diagnostic Accuracy and Innovation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
Polsinelli PC filed a lobbying registration on Oct. 11, 2018 to represent American Society for Histocompatibility & Immunogenetics, effective Oct. 1, 2018.
Original Filing: 300984512.xml
Issue(s) they said they’d lobby about: Issues relating to Medicare reimbursement for clinical laboratory services; Appropriate regulatory and oversight framework .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate